Omega Therapeutics Inc (OMGA) — Cash Flow-to-Debt Ratio
Latest as of September 2024:
-0.10x
Omega Therapeutics Inc (OMGA) has a Cash Flow-to-Debt Ratio of -0.10x as of September 2024, meaning its operating cash flow of $-14.02 Million could theoretically repay 0% of its total liabilities ($141.18 Million) in one year. See OMGA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.10x
Operating CF / Total Liabilities
Operating Cash Flow
$-14.02 Million
USD
Total Liabilities
$141.18 Million
USD
Data as of
Sep 2024
Most recent filing
Omega Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2023)
Historical debt coverage capacity for Omega Therapeutics Inc across 5 annual periods. For the full cash flow conversion analysis, see OMGA operating cash flow.
Annual Cash Flow-to-Debt Ratio for Omega Therapeutics Inc (2019–2023)
Year-by-year debt coverage analysis for Omega Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.63x | $-91.51 Million | $146.35 Million | ▲ +74.6% |
| 2022 | -2.46x | $-98.52 Million | $40.03 Million | ▼ -39.7% |
| 2021 | -1.76x | $-57.61 Million | $32.70 Million | ▼ -524.9% |
| 2020 | -0.28x | $-26.13 Million | $92.71 Million | ▲ +24.4% |
| 2019 | -0.37x | $-15.68 Million | $42.04 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.